Exhibit 2.
Inpatient admissions per twelve months for those filling a first prescription for ivacaftor, by number of prescription fills during the first 12 months of ivacaftor use, 2012–15
| Before filling prescription
|
After filling prescription
|
Decrease from before to after |
||||
|---|---|---|---|---|---|---|
| Fills | Patients | Admissions | Ratea | Admissions | Ratea | |
| 3–9 | 53 | 20 | 0.38 | 11 | 0.21 | 45% |
| 10–12 | 90 | 28 | 0.31 | 9 | 0.10 | 68% |
SOURCE Authors’ analysis of data from the Truven Health Analytics MarketScan Commercial Research database.
NOTES Patients’ diagnosis codes, prescription fills, insurance coverage, and age are explained in the notes to exhibit 1. Inpatient admissions were for all causes. Information about patients with 1–2 fills is not shown because of the small sample size.
a
Per person per year.